Recursion Pharmaceuticals Inc Cash Flow Reinvestment Rate

Latest as of March 2022: 1.96x

Recursion Pharmaceuticals Inc cash flow reinvestment rate. Recursion Pharmaceuticals Inc (RXRX) has a Cash Flow Reinvestment Rate of 1.96x as of March 2022, reinvesting $151.99 Million (capex $4.34 Million plus investments $147.65 Million) from operating cash flow of $77.39 Million. Explore RXRX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

1.96x
(Capex + Investments) / Operating CF

Total Reinvested

$151.99 Million
Capex + Investments

Operating Cash Flow

$77.39 Million
USD

Capital Expenditures

$4.34 Million
USD

Recursion Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (None–None)

Recursion Pharmaceuticals Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Recursion Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Recursion Pharmaceuticals Inc.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow